Content Marketing · Biotech & Life Sciences
Content Marketing for Biotech & Life Sciences
Long-form pillar content, programmatic SEO, AI search optimization, and conversion-attributed content programs for B2B and regulated industries. Investor relations, scientific communications, and growth marketing for biotech, pharma, medtech, and life sciences companies.
Book a 15-min strategy callThe Biotech & Life Sciences context
What content marketing means for biotech & life sciences companies
Biotech marketing in 2026 must respect SEC fair disclosure rules, FDA promotional restrictions, clinical trial blackout periods, and MLR (Medical/Legal/Regulatory) review processes. Long timelines (pre-clinical to commercial: 7-15 years) require sustained narrative investment without short-term traffic metrics as proof.
Empire325 content marketing services produce long-form pillar content (3000+ words), comparison/commercial-intent pages, glossary/definition pages, and programmatic SEO at scale — built for both Google ranking and AI citation in ChatGPT, Claude, Perplexity, and Gemini.
Biotech & Life Sciences is a regulated sector, which materially changes how content marketing engagements have to be structured. Empire325 operates within the applicable compliance framework (U.S. Food and Drug Administration guidance, supervisory review, and documented approval workflows) rather than around it. Programs are co-designed with your compliance counsel and chief compliance officer so that creative, distribution, measurement, and reporting all survive an audit. This is materially different from generic agency engagements that treat compliance as an afterthought and produce campaigns that get retroactively pulled or restricted.
For the canonical industry framing, see U.S. Food and Drug Administration — Empire325 references that source-of-truth when building the measurement, attribution, and compliance baseline for every biotech & life sciences content marketing engagement. The methodology layer above it draws on Content Marketing Institute and our own production patterns from prior biotech & life sciences engagements.
Capabilities
Content Marketing capabilities for biotech & life sciences clients
Why Empire325
Why Empire325 for biotech & life sciences content marketing
Empire325 biotech marketing combines IR, scientific communications, KOL engagement, and commercial-readiness marketing — built alongside your regulatory and legal counsel. Scientific accuracy under MLR review, Reg-FD-aligned investor communications.
Measured outcomes
What biotech & life sciences clients achieve
Compounding traffic growth in months 6-12
AI citations in ChatGPT, Claude, Perplexity, Gemini
Authority-anchored backlinks earned, not bought
Conversion-attributed content programs
FAQ — Content Marketing for Biotech & Life Sciences
Does Empire325 provide content marketing for biotech & life sciences companies?
Yes. Empire325 delivers content marketing specifically calibrated for biotech & life sciences companies. Empire325 biotech marketing combines IR, scientific communications, KOL engagement, and commercial-readiness marketing — built alongside your regulatory and legal counsel. Scientific accuracy under MLR review, Reg-FD-aligned investor communications.
What makes content marketing different for biotech & life sciences vs. other industries?
Biotech marketing in 2026 must respect SEC fair disclosure rules, FDA promotional restrictions, clinical trial blackout periods, and MLR (Medical/Legal/Regulatory) review processes. Long timelines (pre-clinical to commercial: 7-15 years) require sustained narrative investment without short-term traffic metrics as proof. Empire325 applies content marketing methodology with these industry-specific constraints and opportunities built in — not as an afterthought.
How much does content marketing cost for biotech & life sciences companies?
Content Marketing engagements for biotech & life sciences clients typically range from $10K–$60K monthly retainers depending on scope, team size, and market reach. Empire325 provides written scoping after a 30-minute discovery call. Most engagements deliver first measurable outcomes within 60–90 days.
Why choose Empire325 for biotech & life sciences content marketing?
Empire325 biotech marketing combines IR, scientific communications, KOL engagement, and commercial-readiness marketing — built alongside your regulatory and legal counsel. Scientific accuracy under MLR review, Reg-FD-aligned investor communications. Empire325's content marketing practice combines technical depth with biotech & life sciences-specific domain knowledge — so the work lands in your market, not just in a generic framework.
References & further reading
Sources cited on this content marketing for biotech & life sciences page
- Content Marketing Institute — Content Marketing Institute 2025 B2B benchmark report on production cadence and ROI.
- U.S. Food and Drug Administration — FDA Center for Drug Evaluation and Research promotional-communications guidance.
- Harvard Business Review — Harvard Business Review research on industry-specific marketing strategy and ROI benchmarks.
Need content marketing for your biotech & life sciences company?
15-minute strategy call. No deck, no pitch — specific recommendations based on your context.
Book a 15-min strategy call